BR112018077463A2 - preparação, e, método de aplicação da mesma. - Google Patents

preparação, e, método de aplicação da mesma.

Info

Publication number
BR112018077463A2
BR112018077463A2 BR112018077463-4A BR112018077463A BR112018077463A2 BR 112018077463 A2 BR112018077463 A2 BR 112018077463A2 BR 112018077463 A BR112018077463 A BR 112018077463A BR 112018077463 A2 BR112018077463 A2 BR 112018077463A2
Authority
BR
Brazil
Prior art keywords
preparation
pythium oligandrum
microorganism
mycoparasitic
weight
Prior art date
Application number
BR112018077463-4A
Other languages
English (en)
Other versions
BR112018077463B1 (pt
Inventor
Suchánek Martin
Klimes Radim
Original Assignee
Bio Agens Research And Development- Bard S.R.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ2016-417A external-priority patent/CZ307642B6/cs
Application filed by Bio Agens Research And Development- Bard S.R.O. filed Critical Bio Agens Research And Development- Bard S.R.O.
Publication of BR112018077463A2 publication Critical patent/BR112018077463A2/pt
Publication of BR112018077463B1 publication Critical patent/BR112018077463B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

uma preparação contendo o micro-organismo micoparasítico pythium oligandrum para o tratamento de dermatofitoses e de infecções por leveduras sobre a pele e as membranas mucosas obtida a partir de uma mistura seca contendo de 0,1 a 99,9% em peso de micro-organismo micoparasítico pythium oligandrum e de 0,1 a 99,9% em peso de substâncias auxiliares, contendo pelo menos um componente de um grupo compreendendo absorvente, agente tamponante, agente umectante, desodorante e aroma. esta preparação contém de 1 a 10 x 106, com preferência de 10 a 50, células viáveis do micro-organismo pythium oligandrum por 1 ml de suspensão aquosa no sítio de aplicação da preparação, pela qual as células viáveis do micro-organismo pythium oligandrum compreendem oósporos dormentes, zoósporos encistados e micélio coenocítico viável. são reivindicados diferentes métodos de aplicação. modalidades exemplificadoras mostram a viabilidade de células usando testes genéticos e testes práticos conduzidos sob a supervisão de dermatologistas, estomatologistas e veterinários.
BR112018077463-4A 2016-07-01 2016-08-22 Preparação contendo o micro-organismo micoparasítico pythium oligandrum cepa dv74 BR112018077463B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CZ2016403 2016-07-01
CZPV2016-403 2016-07-01
CZ2016-417A CZ307642B6 (cs) 2016-07-08 2016-07-08 Přípravek s mykoparazitickým mikroorganizmem Pythium oligandrum pro užití při léčbě dermatofytos a kvasinkových infekcí na kůži a sliznicích
CZPV2016-417 2016-07-08
PCT/CZ2016/000095 WO2018001392A1 (en) 2016-07-01 2016-08-22 Preparation with the viable mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucous membranes, method of determining the cell's viability of the microorganism pythium oligandrum and method of applying the preparation

Publications (2)

Publication Number Publication Date
BR112018077463A2 true BR112018077463A2 (pt) 2019-04-02
BR112018077463B1 BR112018077463B1 (pt) 2021-12-07

Family

ID=66847908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018077463-4A BR112018077463B1 (pt) 2016-07-01 2016-08-22 Preparação contendo o micro-organismo micoparasítico pythium oligandrum cepa dv74

Country Status (10)

Country Link
US (1) US11331356B2 (pt)
EP (1) EP3478302B1 (pt)
JP (2) JP6667501B2 (pt)
KR (1) KR20190064563A (pt)
CN (1) CN110225759B (pt)
BR (1) BR112018077463B1 (pt)
CA (1) CA3029484A1 (pt)
ES (1) ES2957887T3 (pt)
MX (1) MX2019000269A (pt)
WO (1) WO2018001392A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019530455A (ja) * 2016-10-14 2019-10-24 バイオプレパラティ、 スポル． エス．アール．オー 微生物ピシウム・オリガンドラムを含む生物学的抗真菌液体製品及び製造方法
CZ309743B6 (cs) * 2021-12-14 2023-09-06 Ústav chemických procesů AV ČR, v.v.i. Způsob výroby extraktu z Pythium oligandrum pro potlačení růstu buněk kožního melanomu, extrakt připravitelný tímto způsobem a jeho použití

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS213659B1 (en) * 1978-07-05 1982-04-09 Dasa Vesely Means for protection the sugar beet against the scarlet fever on the base of cospor mykroparazita pythium oligandrum
US5961971A (en) * 1996-10-17 1999-10-05 University Of Florida Biocontrol of fungal soilborne pathogens by Pythium oligandrum
CZ9883U1 (cs) 1999-11-18 2000-04-14 Dasa Doc Ing Drsc Vesely Prostředek na ochranu pokožky využívající houbu Pythium oligandrum
CZ2009724A3 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
WO2012077061A1 (en) * 2010-12-08 2012-06-14 Basf Se Pesticidal mixtures
MA40779B1 (fr) * 2014-10-02 2019-05-31 Bayer Cropscience Biologics Gmbh Composition essentiellement exempte d'eau et comportant au moins un biopesticide à formation de spores fongiques, un trisiloxane modifié au polyéther et de la silice fumée ou précipitée
CZ201523A3 (cs) * 2015-01-16 2016-07-27 Bio Agens Research And Development - Bard, S.R.O. Duální mikrobiální preparát pro dlouhodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí
CZ28816U1 (cs) * 2015-01-16 2015-11-16 Bio Agens Research And Development - Bard, S.R.O. Duální mikrobiální preparát pro dloubodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí
CN105274241A (zh) * 2015-11-21 2016-01-27 云南省烟草公司大理州公司 一种烟草根黑腐病菌分子检测引物及其快速检测方法

Also Published As

Publication number Publication date
WO2018001392A1 (en) 2018-01-04
EP3478302B1 (en) 2023-07-05
US20200085893A1 (en) 2020-03-19
MX2019000269A (es) 2019-05-27
JP2018528154A (ja) 2018-09-27
BR112018077463B1 (pt) 2021-12-07
CN110225759B (zh) 2023-09-29
CA3029484A1 (en) 2018-01-04
JP6667501B2 (ja) 2020-03-18
EP3478302A1 (en) 2019-05-08
ES2957887T3 (es) 2024-01-29
US11331356B2 (en) 2022-05-17
JP2020073475A (ja) 2020-05-14
CN110225759A (zh) 2019-09-10
KR20190064563A (ko) 2019-06-10

Similar Documents

Publication Publication Date Title
BR112016022814A8 (pt) composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
AR113142A1 (es) Moléculas de unión al antígeno multiespecíficas que tienen actividad de sustitución de la función de cofactor del factor viii de coagulación de sangre (fviii), y formulaciones farmacéuticas que contienen dicha molécula como ingrediente activo
BR112017014060A2 (pt) composições de bacillus licheniformis rti184 e métodos de uso para beneficiar o crescimento de plantas
PE20131063A1 (es) Composicion acuosa que contiene bromhexina
BR112017023380A2 (pt) sistema, composição cosmética, métodos para tratamento de substratos queratinosos e para proteção e/ou alisamento da fibra do cabelo, kit multicompartimento, e, processo para alisamento do cabelo.
CL2015001960A1 (es) (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
BRPI0821145B8 (pt) uso de um anticorpo anti-nr10 como agente preventivo ou terapêutico para prurido
BR112013018352A2 (pt) composição de minociclina tópica e método
BRPI0921726B8 (pt) método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero
BR112014016672A2 (pt) compostos de carbamato e sua preparação e uso
AR067011A1 (es) Formulaciones de anticuerpos
AR071917A1 (es) Vacunas contra la coccidiosis
BR112012033548A2 (pt) métodos e composições para melhorar a mobilização de células-tronco
BR112012032193A2 (pt) composto, composiçoes e métodos de uso de feniltioacetato
BR112018007560A2 (pt) composição cosmética tendo bactérias probióticas
AR068419A1 (es) Cepas de mycoplasma atenuadas vivas
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
BR112015026685A2 (pt) agente de diminuição de ácido úrico
AR068418A1 (es) Bacteria mycoplasma gallisepticum atenuada, composicion de vacuna, metodos para identificar clones de mycoplasma gallisepticum atenuados y vacunar un animal contra infeccion de mycoplasma gallisepticum
BR112021017878A2 (pt) Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação
BR112018077463A2 (pt) preparação, e, método de aplicação da mesma.
MX2020003833A (es) Uso de composiciones que contienen streptomyces melanosporofaciens agl225 en el control de enfermedades de las plantas.
AR107701A1 (es) Composición cosmética bifásica y su uso mediante aplicación tópica
BR112012017159A2 (pt) solução aquosa de polímeros ramificados combinados com fluido metacrílico, com um teor de sólidos maior do que 60%, método de fabricação e uso como um agente plastificante.
BR112019006009A2 (pt) método não terapêutico, partícula ou composição e uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/08/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 8A ANUIDADE.

B24D Patent annual fee: restoration after fee payment